TALPHERA, INC.
TLPHDrugs in Pipeline
10
Phase 3 Programs
6
Upcoming Catalysts
2
Next Catalyst
Aug 13, 2026
5wMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
How TLPH's past catalysts played out
sufentanil sublingual 30 mcg tablet
Moderate-to-severe Acute Pain
morphine IV PCA
Post-Operative Pain
sufentanil sublingual tablet 30 mcg
Acute Moderate-to-severe Pain
Zalviso™ 15 mcg
Moderate-to-severe Acute Pain
Sufentanil Tablet 30 mcg
Post-Operative Pain
Sufentanil NanoTab PCA System/15 mcg
Pain, Postoperative
Oral sufentanil
Major Upper or Lower Abdominal Surgery
Sufentanil NanoTab
Post Operative Pain
Sufentanil NanoTab 20 mcg
Acute Pain
Sublingual Sufentanil/Triazolam NanoTab™ (ARX-F03)
Sedation
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
sufentanil sublingual 30 mcg tablet | Phase 3 | Moderate-to-severe Acute Pain | - | - |
morphine IV PCA | Phase 3 | Post-Operative Pain | - | - |
sufentanil sublingual tablet 30 mcg | Phase 3 | Acute Moderate-to-severe Pain | - | - |
Zalviso™ 15 mcg | Phase 3 | Moderate-to-severe Acute Pain | - | - |
Sufentanil Tablet 30 mcg | Phase 3 | Post-Operative Pain | - | - |
Sufentanil NanoTab PCA System/15 mcg | Phase 3 | Pain, Postoperative | - | - |
Oral sufentanil | Phase 2 | Major Upper or Lower Abdominal Surgery | - | - |
Sufentanil NanoTab | Phase 2 | Post Operative Pain | - | - |
Sufentanil NanoTab 20 mcg | Phase 2 | Acute Pain | - | - |
Sublingual Sufentanil/Triazolam NanoTab™ (ARX-F03) | Phase 2 | Sedation | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in TALPHERA, INC.'s drug pipeline?→
CatalystAlert tracks 10 drug candidates in TALPHERA, INC.'s (TLPH) pipeline across Phase 3, Phase 2. Its lead program is sufentanil sublingual 30 mcg tablet (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is TALPHERA, INC.'s next FDA catalyst?→
TALPHERA, INC.'s (TLPH) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TLPH biotech catalysts?→
Add TLPH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow TALPHERA, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.